PREDICTIVE FACTORS OF SURVIVAL AFTER NEOADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST CANCER

被引：0
|
作者：
Matuschek, Christiane [1 ]
Budach, Wilfried [1 ]
Tamaskovics, Balint [1 ]
Fischer, Johannes [1 ]
Boelke, Edwin [1 ]
Corradini, Stefanie [2 ]
Kammers, Kai [3 ]
Kraemling, Carolin Nestle [1 ]
Fehm, Tanja [1 ]
Wollandt, Sylvia [1 ]
Speer, Vanessa [1 ]
Haussmann, Jan [1 ]
机构：
[1] Heinrich Heine Univ, Dusseldorf, Germany
[2] Univ Hosp LMU, Munich, Germany
[3] Johns Hopkins Univ, Baltimore, MD USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 163卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
86
引用
收藏
页码：S38 / S39
页数：2
相关论文
共 50 条
  • [21] CONCOMITANT ADJUVANT CHEMOTHERAPY AND RADIOTHERAPY FOR HIGH-RISK BREAST-CANCER PATIENTS
    HANSEN, R
    ERICKSON, B
    KOMAKI, R
    JANJAN, N
    COX, J
    WILSON, JF
    ANDERSON, T
    BREAST CANCER RESEARCH AND TREATMENT, 1991, 17 (03) : 171 - 177
  • [22] CONCOMITANT CHEMOTHERAPY AND RADIOTHERAPY AS ADJUVANTS TO MASTECTOMY IN HIGH-RISK BREAST-CANCER
    HANSEN, R
    KOMAKI, R
    RITCH, P
    WILSON, J
    FRICK, J
    COX, J
    ANDERSON, T
    BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 169 - 169
  • [23] Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer
    Thomae, Keith
    Sargent
    Russell, Christy A.
    Russell
    AMERICAN JOURNAL OF SURGERY, 2022, 223 (03): : 543 - 543
  • [24] Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer
    Ryan, CJ
    Zelefsky, MJ
    Heller, G
    Regan, K
    Leibel, SA
    Scher, HI
    Kelly, WK
    UROLOGY, 2004, 64 (01) : 90 - 94
  • [25] Utilization of neoadjuvant chemotherapy in high-risk, node-negative early breast cancer
    Prakash, Ipshita
    Ben Neely, N.
    Thomas, Samantha M.
    Sammons, Sarah
    Blitzblau, Rachel C.
    DiLalla, Gayle A.
    Hyslop, Terry
    Menendez, Carolyn S.
    Plichta, Jennifer K.
    Rosenberger, Laura H.
    Fayanju, Oluwadamilola M.
    Hwang, E. Shelley
    Greenup, Rachel A.
    CANCER MEDICINE, 2022, 11 (04): : 1099 - 1108
  • [26] Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
    Cottu, P.
    D'Hondt, V.
    Dureau, S.
    Lerebours, F.
    Desmoulins, I.
    Heudel, P-E
    Duhoux, F. P.
    Levy, C.
    Mouret-Reynier, M-A
    Dalenc, F.
    Frenel, J-S
    Jouannaud, C.
    Venat-Bouvet, L.
    Nguyen, S.
    Ferrero, J-M
    Canon, J-L
    Grenier, J.
    Callens, C.
    Gentien, D.
    Lemonnier, J.
    Vincent-Salomon, A.
    Delaloge, S.
    ANNALS OF ONCOLOGY, 2018, 29 (12) : 2334 - 2340
  • [27] Predictive factors of invasive breast cancer recurrence for patients achieving pCR after neoadjuvant chemotherapy
    Onomura, Mai
    Naito, Yoichi
    Sasaki, Masaoki
    Matsubara, Nobuaki
    Kogawa, Takahiro
    Hosono, Ako
    Yamada, Yoko
    Yoneyama, Kimiyasu
    Fujii, Satoshi
    Mukai, Hirofumi
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] Are there predictive factors for a pathological complete response after neoadjuvant chemotherapy in locally advanced breast cancer?
    Warm, M.
    Cramer, E-M
    Bosse, K.
    Moers, C.
    Thomas, A.
    Mallmann, P.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S154 - S154
  • [29] Radiotherapy after high-dose chemotherapy and peripheral blood stem cell support in high-risk breast cancer
    Hoeller, U
    Heide, J
    Kroeger, N
    Krueger, W
    Jaenicke, F
    Alberti, W
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (05): : 1234 - 1239
  • [30] Factors predictive of local-regional control and survival in patients with breast cancer refractory to neoadjuvant chemotherapy
    Hill, BS
    Buchholz, TA
    Tucker, SL
    Frye, DK
    Kuerer, HK
    Buzdar, AU
    RADIOLOGY, 2000, 217 : 440 - 441
12345